US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 19.020
  • -0.250-1.30%
Close Dec 20 16:00 ET
  • 19.020
  • -0.0010.00%
Post 16:30 ET
483.39MMarket Cap-0.41P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-94.09%387K
537.17%33.45M
-1.65%5.84M
-76.53%26M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
30.21%110.78M
-43.90%16.8M
Operating revenue
-94.09%387K
537.17%33.45M
-1.65%5.84M
-76.53%26M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
30.21%110.78M
-43.90%16.8M
Cost of revenue
Gross profit
Operating expense
-8.43%17.96M
-17.58%19.69M
-21.10%19.19M
16.81%112.42M
76.34%44.6M
-12.07%19.62M
-6.00%23.89M
4.71%24.32M
7.32%96.24M
-2.20%25.29M
Selling and administrative expenses
-0.79%6.56M
15.10%7.03M
65.94%9.45M
70.07%40.58M
250.52%22.17M
14.63%6.61M
-2.02%6.11M
2.85%5.7M
13.97%23.86M
14.13%6.32M
-General and administrative expense
-0.79%6.56M
15.10%7.03M
65.94%9.45M
70.07%40.58M
250.52%22.17M
14.63%6.61M
-2.02%6.11M
2.85%5.7M
13.97%23.86M
14.13%6.32M
Research and development costs
-12.32%11.4M
-28.80%12.66M
-47.71%9.74M
-0.74%71.84M
18.26%22.43M
-21.39%13M
-7.30%17.78M
5.29%18.62M
5.30%72.38M
-6.65%18.97M
Operating profit
-34.52%-17.58M
173.81%13.76M
27.38%-13.35M
-694.41%-86.42M
-327.64%-36.33M
-717.07%-13.07M
-234.47%-18.64M
-270.62%-18.38M
416.25%14.54M
-308.34%-8.5M
Net non-operating interest income expense
0
0
0
6.53%-2.83M
0
-58.73%-1.27M
-5.17%-752K
-14.29%-808K
-6.58%-3.03M
-13.50%-807K
Non-operating interest expense
--0
--0
--0
-6.53%2.83M
--0
58.73%1.27M
5.17%752K
14.29%808K
6.58%3.03M
13.50%807K
Other net income (expense)
-223.84%-6.61M
-99.01%79K
-1,657.32%-43.48M
-742.48%-149.46M
-1,175.44%-160.33M
191.79%5.34M
276.12%8M
-113.22%-2.47M
1,120.31%23.26M
65.46%14.91M
Gain on sale of security
62.15%8.24M
-134.97%-2.71M
-71.64%-4.68M
-674.94%-131.85M
-1,063.58%-141.96M
187.43%5.08M
270.73%7.76M
-114.71%-2.73M
1,099.26%22.93M
63.52%14.73M
Special income (charges)
---15.1M
--2.5M
---39.3M
---18.3M
---18.3M
--0
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
--15.1M
---2.5M
--39.3M
--18.3M
--18.3M
--0
--0
--0
--0
----
Other non- operating income (expenses)
-1.19%250K
19.18%292K
99.22%508K
109.39%691K
-135.43%-62K
25,200.00%253K
--245K
65.58%255K
2,100.00%330K
--175K
Income before tax
-168.64%-24.18M
221.51%13.84M
-162.31%-56.82M
-786.54%-238.71M
-3,608.62%-196.66M
-9.59%-9M
-232.39%-11.39M
-175.28%-21.66M
457.68%34.77M
-54.71%5.61M
Income tax
-3,019.87%-19M
-103.81%-609K
-308.70%-288K
Net income
-168.64%-24.18M
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
Net income continuous Operations
-168.64%-24.18M
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
Minority interest income
Net income attributable to the parent company
-168.64%-24.18M
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
Preferred stock dividends
Other preferred stock dividends
4.21M
0
Net income attributable to common stockholders
-168.64%-24.18M
184.55%9.63M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
Basic earnings per share
-94.83%-3.39
126.01%0.58
-147.64%-10.5
-791.67%-49.8
-4,722.22%-41.6
-16.00%-1.74
-223.89%-2.23
-161.45%-4.24
209.09%7.2
-70.00%0.9
Diluted earnings per share
-94.83%-3.39
124.22%0.54
-147.64%-10.5
-1,760.00%-49.8
-2,673.33%-41.6
-16.00%-1.74
-223.89%-2.23
-276.67%-4.24
145.45%3
-266.67%-1.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -94.09%387K537.17%33.45M-1.65%5.84M-76.53%26M-50.78%8.27M-68.37%6.55M-86.63%5.25M-82.53%5.94M30.21%110.78M-43.90%16.8M
Operating revenue -94.09%387K537.17%33.45M-1.65%5.84M-76.53%26M-50.78%8.27M-68.37%6.55M-86.63%5.25M-82.53%5.94M30.21%110.78M-43.90%16.8M
Cost of revenue
Gross profit
Operating expense -8.43%17.96M-17.58%19.69M-21.10%19.19M16.81%112.42M76.34%44.6M-12.07%19.62M-6.00%23.89M4.71%24.32M7.32%96.24M-2.20%25.29M
Selling and administrative expenses -0.79%6.56M15.10%7.03M65.94%9.45M70.07%40.58M250.52%22.17M14.63%6.61M-2.02%6.11M2.85%5.7M13.97%23.86M14.13%6.32M
-General and administrative expense -0.79%6.56M15.10%7.03M65.94%9.45M70.07%40.58M250.52%22.17M14.63%6.61M-2.02%6.11M2.85%5.7M13.97%23.86M14.13%6.32M
Research and development costs -12.32%11.4M-28.80%12.66M-47.71%9.74M-0.74%71.84M18.26%22.43M-21.39%13M-7.30%17.78M5.29%18.62M5.30%72.38M-6.65%18.97M
Operating profit -34.52%-17.58M173.81%13.76M27.38%-13.35M-694.41%-86.42M-327.64%-36.33M-717.07%-13.07M-234.47%-18.64M-270.62%-18.38M416.25%14.54M-308.34%-8.5M
Net non-operating interest income expense 0006.53%-2.83M0-58.73%-1.27M-5.17%-752K-14.29%-808K-6.58%-3.03M-13.50%-807K
Non-operating interest expense --0--0--0-6.53%2.83M--058.73%1.27M5.17%752K14.29%808K6.58%3.03M13.50%807K
Other net income (expense) -223.84%-6.61M-99.01%79K-1,657.32%-43.48M-742.48%-149.46M-1,175.44%-160.33M191.79%5.34M276.12%8M-113.22%-2.47M1,120.31%23.26M65.46%14.91M
Gain on sale of security 62.15%8.24M-134.97%-2.71M-71.64%-4.68M-674.94%-131.85M-1,063.58%-141.96M187.43%5.08M270.73%7.76M-114.71%-2.73M1,099.26%22.93M63.52%14.73M
Special income (charges) ---15.1M--2.5M---39.3M---18.3M---18.3M--0--0--0--0----
-Less：Restructuring and merger&acquisition --15.1M---2.5M--39.3M--18.3M--18.3M--0--0--0--0----
Other non- operating income (expenses) -1.19%250K19.18%292K99.22%508K109.39%691K-135.43%-62K25,200.00%253K--245K65.58%255K2,100.00%330K--175K
Income before tax -168.64%-24.18M221.51%13.84M-162.31%-56.82M-786.54%-238.71M-3,608.62%-196.66M-9.59%-9M-232.39%-11.39M-175.28%-21.66M457.68%34.77M-54.71%5.61M
Income tax -3,019.87%-19M-103.81%-609K-308.70%-288K
Net income -168.64%-24.18M221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M
Net income continuous Operations -168.64%-24.18M221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M
Minority interest income
Net income attributable to the parent company -168.64%-24.18M221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M
Preferred stock dividends
Other preferred stock dividends 4.21M0
Net income attributable to common stockholders -168.64%-24.18M184.55%9.63M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M
Basic earnings per share -94.83%-3.39126.01%0.58-147.64%-10.5-791.67%-49.8-4,722.22%-41.6-16.00%-1.74-223.89%-2.23-161.45%-4.24209.09%7.2-70.00%0.9
Diluted earnings per share -94.83%-3.39124.22%0.54-147.64%-10.5-1,760.00%-49.8-2,673.33%-41.6-16.00%-1.74-223.89%-2.23-276.67%-4.24145.45%3-266.67%-1.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data